Agilent Receives European IVDR Class C Certification For GenetiSure Dx Postnatal Assay
Portfolio Pulse from Benzinga Newsdesk
Agilent Technologies, Inc. has received the European IVDR Class C certification for its GenetiSure Dx Postnatal Assay, marking a significant regulatory milestone that allows the product to be sold across Europe. This certification is crucial for diagnostic tests in the European market, indicating that Agilent's assay meets high safety, quality, and performance standards.
April 15, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Agilent Technologies, Inc.'s receipt of the European IVDR Class C certification for its GenetiSure Dx Postnatal Assay is a positive development, likely to enhance its market presence in Europe and potentially boost sales.
The IVDR Class C certification is a significant regulatory approval that allows Agilent to market its GenetiSure Dx Postnatal Assay across Europe. This approval is likely to increase the product's sales and enhance Agilent's reputation in the diagnostics market. The certification indicates that the product meets high safety, quality, and performance standards, which is crucial for gaining customer trust and expanding market share in the competitive European diagnostics market.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90